These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1956 related articles for article (PubMed ID: 8838863)
1. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands. Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863 [TBL] [Abstract][Full Text] [Related]
2. Expression of nuclear retinoic acid receptors in wild-type and mutant embryonal carcinoma PCC4.aza1R cells. Nervi C; Vollberg TM; Grippo JF; Lucas DA; George MD; Sherman MI; Shudo K; Jetten AM Cell Growth Differ; 1990 Nov; 1(11):535-42. PubMed ID: 1965138 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells. Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids. Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the factors involved in the retinoic acid-induced differentiation of a retinoid-hypersensitive embryonal carcinoma cell mutant. Dietrich JM; McCormick PJ Exp Cell Res; 1994 Feb; 210(2):201-8. PubMed ID: 8299717 [TBL] [Abstract][Full Text] [Related]
6. Different response to retinoic acid of two teratocarcinoma cell lines. Wan YJ; Wang L; Wu TC Exp Cell Res; 1995 Aug; 219(2):392-8. PubMed ID: 7543852 [TBL] [Abstract][Full Text] [Related]
7. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of the retinoic acid receptor gamma directly induces terminal differentiation of human embryonal carcinoma cells. Moasser MM; Reuter VE; Dmitrovsky E Oncogene; 1995 Apr; 10(8):1537-43. PubMed ID: 7731708 [TBL] [Abstract][Full Text] [Related]
9. Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells. Zou CP; Hong WK; Lotan R Differentiation; 1999 Jan; 64(2):123-32. PubMed ID: 10234809 [TBL] [Abstract][Full Text] [Related]
10. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers. Lotan R Anticancer Res; 1996; 16(4C):2415-9. PubMed ID: 8816844 [TBL] [Abstract][Full Text] [Related]
11. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Zou CP; Clifford JL; Xu XC; Sacks PG; Chambon P; Hong WK; Lotan R Cancer Res; 1994 Oct; 54(20):5479-87. PubMed ID: 7522960 [TBL] [Abstract][Full Text] [Related]
12. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells. Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191 [TBL] [Abstract][Full Text] [Related]
13. Genomic footprinting of retinoic acid regulated promoters in embryonal carcinoma cells. Dey A; Ozato K Methods; 1997 Feb; 11(2):197-204. PubMed ID: 8993032 [TBL] [Abstract][Full Text] [Related]
14. Role of retinoid receptors in the regulation of mucin gene expression by retinoic acid in human tracheobronchial epithelial cells. Koo JS; Jetten AM; Belloni P; Yoon JH; Kim YD; Nettesheim P Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):351-7. PubMed ID: 10024510 [TBL] [Abstract][Full Text] [Related]
15. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity. Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153 [TBL] [Abstract][Full Text] [Related]
16. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells. Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055 [TBL] [Abstract][Full Text] [Related]
17. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells. Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495 [TBL] [Abstract][Full Text] [Related]
19. The expression of retinoid X receptor genes is regulated by all-trans- and 9-cis-retinoic acid in F9 teratocarcinoma cells. Wan YJ; Wang L; Wu TC Exp Cell Res; 1994 Jan; 210(1):56-61. PubMed ID: 8269997 [TBL] [Abstract][Full Text] [Related]
20. Receptor-selective retinoid agonists and teratogenic activity. Willhite CC; Dawson MI; Reichert U Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]